A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in the United States and Canada. Renejix provided integrated development, manufacturing, and clinical supply solutions. Clinix Total Supply is an integrated method that integrates early-phase development with clinical supply production and distribution to shorten the road to the clinic. This complete method was implemented to enhance supply chain management and accelerate development schedules. This case study focuses on the problems encountered, the techniques used, and the results obtained via the deployment of an integrated development, manufacturing, and clinical supply solution.
